Oppenheimer Lowers Teladoc Health (NYSE:TDOC) Price Target to $12.00

Teladoc Health (NYSE:TDOCGet Free Report) had its price objective cut by analysts at Oppenheimer from $14.00 to $12.00 in a research note issued on Friday,Benzinga reports. The brokerage presently has an “outperform” rating on the health services provider’s stock. Oppenheimer’s price target indicates a potential upside of 17.47% from the stock’s previous close.

Other research analysts have also issued reports about the stock. Piper Sandler restated an “overweight” rating and issued a $13.00 target price (up from $11.00) on shares of Teladoc Health in a report on Wednesday, December 4th. Royal Bank of Canada upped their price objective on shares of Teladoc Health from $9.00 to $10.00 and gave the company an “outperform” rating in a research note on Wednesday, October 9th. The Goldman Sachs Group started coverage on Teladoc Health in a research note on Friday, November 15th. They set a “buy” rating and a $14.00 price target for the company. TD Cowen dropped their target price on Teladoc Health from $9.00 to $8.00 and set a “hold” rating on the stock in a report on Thursday, October 31st. Finally, Deutsche Bank Aktiengesellschaft increased their price target on Teladoc Health from $10.00 to $12.00 and gave the company a “hold” rating in a report on Friday, November 1st. Fourteen equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $11.97.

Read Our Latest Analysis on Teladoc Health

Teladoc Health Stock Performance

NYSE TDOC traded up $0.08 during trading hours on Friday, hitting $10.22. 1,535,448 shares of the stock were exchanged, compared to its average volume of 4,090,093. The stock has a 50-day moving average of $9.99 and a 200 day moving average of $9.04. Teladoc Health has a 12-month low of $6.76 and a 12-month high of $21.74. The company has a market cap of $1.76 billion, a price-to-earnings ratio of -1.77 and a beta of 1.01. The company has a quick ratio of 1.69, a current ratio of 1.73 and a debt-to-equity ratio of 0.66.

Teladoc Health (NYSE:TDOCGet Free Report) last issued its quarterly earnings data on Wednesday, October 30th. The health services provider reported ($0.19) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.29) by $0.10. Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. The firm had revenue of $640.51 million during the quarter, compared to the consensus estimate of $630.50 million. As a group, equities research analysts forecast that Teladoc Health will post -1.16 earnings per share for the current year.

Insider Activity

In related news, insider Carlos Nueno sold 2,389 shares of Teladoc Health stock in a transaction dated Monday, December 2nd. The shares were sold at an average price of $11.93, for a total transaction of $28,500.77. Following the completion of the sale, the insider now owns 2,890 shares of the company’s stock, valued at approximately $34,477.70. The trade was a 45.25 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Insiders own 0.95% of the company’s stock.

Institutional Investors Weigh In On Teladoc Health

A number of institutional investors have recently modified their holdings of TDOC. Versant Capital Management Inc increased its position in Teladoc Health by 313.8% during the 4th quarter. Versant Capital Management Inc now owns 3,219 shares of the health services provider’s stock worth $29,000 after purchasing an additional 2,441 shares in the last quarter. Blue Trust Inc. grew its position in Teladoc Health by 84.5% in the 3rd quarter. Blue Trust Inc. now owns 4,048 shares of the health services provider’s stock worth $40,000 after purchasing an additional 1,854 shares in the last quarter. Doheny Asset Management CA purchased a new stake in Teladoc Health during the second quarter worth about $46,000. Benjamin F. Edwards & Company Inc. raised its stake in shares of Teladoc Health by 209.8% during the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 5,015 shares of the health services provider’s stock valued at $49,000 after purchasing an additional 3,396 shares during the period. Finally, Point72 Asia Singapore Pte. Ltd. increased its holdings in Teladoc Health by 194.2% during the 2nd quarter. Point72 Asia Singapore Pte. Ltd. now owns 6,891 shares of the health services provider’s stock worth $67,000 after acquiring an additional 4,549 shares during the period. Institutional investors own 76.82% of the company’s stock.

About Teladoc Health

(Get Free Report)

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.

Featured Articles

Analyst Recommendations for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.